These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12377080)

  • 1. Guidelines for treatment of anthrax.
    Tice AD
    JAMA; 2002 Oct; 288(15):1848; author reply 1848-9. PubMed ID: 12377080
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for treatment of anthrax.
    Meyerhoff A; Murphy D
    JAMA; 2002 Oct; 288(15):1848-9; author reply 1848-9. PubMed ID: 12377082
    [No Abstract]   [Full Text] [Related]  

  • 3. Anthrax as a biological weapon: an old disease that poses a new threat.
    Tasota FJ; Henker RA; Hoffman LA
    Crit Care Nurse; 2002 Oct; 22(5):21-32, 34; quiz 35-6. PubMed ID: 12382615
    [No Abstract]   [Full Text] [Related]  

  • 4. Obiltoxaximab (Anthim) for inhalation anthrax.
    Med Lett Drugs Ther; 2018 Sep; 60(1555):150-151. PubMed ID: 30383733
    [No Abstract]   [Full Text] [Related]  

  • 5. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):909-19. PubMed ID: 11699843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    JAMA; 2001 Nov; 286(20):2536-7. PubMed ID: 11763846
    [No Abstract]   [Full Text] [Related]  

  • 7. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax, 2001.
    JAMA; 2001 Dec; 286(21):2662-3. PubMed ID: 11763854
    [No Abstract]   [Full Text] [Related]  

  • 8. From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    JAMA; 2001 Dec; 286(23):2935-6. PubMed ID: 11787481
    [No Abstract]   [Full Text] [Related]  

  • 9. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and management of anthrax--an update.
    Swartz MN
    N Engl J Med; 2001 Nov; 345(22):1621-6. PubMed ID: 11704686
    [No Abstract]   [Full Text] [Related]  

  • 11. Update: Investigation of bioterrorism-related anthrax, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(45):1008-10. PubMed ID: 11724158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioterrorism threat becomes reality.
    Ready T
    Nat Med; 2001 Nov; 7(11):1167. PubMed ID: 11689863
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of inhalational anthrax in the U.S. outbreak.
    Brookmeyer R; Blades N
    Science; 2002 Mar; 295(5561):1861. PubMed ID: 11884746
    [No Abstract]   [Full Text] [Related]  

  • 14. From the Centers for Disease Control and Prevention. Additional options for preventive treatment for exposed persons to inhalational anthrax.
    JAMA; 2002 Feb; 287(5):579. PubMed ID: 11838446
    [No Abstract]   [Full Text] [Related]  

  • 15. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioterrorism. Researchers question obsession with Cipro.
    Enserink M
    Science; 2001 Oct; 294(5543):759-61. PubMed ID: 11679638
    [No Abstract]   [Full Text] [Related]  

  • 18. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax--Connecticut, 2001.
    JAMA; 2001 Dec; 286(23):2936-7. PubMed ID: 11787482
    [No Abstract]   [Full Text] [Related]  

  • 20. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1051-4. PubMed ID: 11808926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.